Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HDAC and MAPK/ERK Inhibitors Cooperate To Reduce Viability and Stemness in Medulloblastoma
Mariane da Cunha Jaeger, Eduarda Chiesa Ghisleni, Paula Schoproni Cardoso, et al.
Journal of Molecular Neuroscience (2020) Vol. 70, Iss. 6, pp. 981-992
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy
M. Janaki Ramaiah, Anjana Devi Tangutur, M. Rajasekhar Reddy
Life Sciences (2021) Vol. 277, pp. 119504-119504
Closed Access | Times Cited: 224
Current and future therapeutic strategies for high-grade gliomas leveraging the interplay between epigenetic regulators and kinase signaling networks
Lea Stitzlein, Jack T. Adams, Erin N. Stitzlein, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential
Alexandre Perla, Lívia Fratini, Paula Schoproni Cardoso, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 40
Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics
Daniil Sokolov, Neha Sharda, Aindrila Banerjee, et al.
Current Pharmaceutical Design (2023) Vol. 30, Iss. 1, pp. 31-47
Closed Access | Times Cited: 15
Discovery of Novel Src Homology-2 Domain-Containing Phosphatase 2 and Histone Deacetylase Dual Inhibitors with Potent Antitumor Efficacy and Enhanced Antitumor Immunity
Meng Liu, Shan Gao, Liang Tao, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 12200-12218
Closed Access | Times Cited: 20
De-Ubiquitinating Enzymes USP21 Regulate MAPK1 Expression by Binding to Transcription Factor GATA3 to Regulate Tumor Growth and Cell Stemness of Gastric Cancer
Qingqu Guo, Dike Shi, Lele Lin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26
Targeting the epigenome of cancer stem cells in pediatric nervous system tumors
Natália Hogetop Freire, Mariane da Cunha Jaeger, Caroline Brunetto de Farias, et al.
Molecular and Cellular Biochemistry (2023) Vol. 478, Iss. 10, pp. 2241-2255
Closed Access | Times Cited: 10
Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres
Natália Hogetop Freire, Alice Laschuk Herlinger, Júlia Vanini, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 72-72
Open Access
Real-time sensing of MAPK signaling in medulloblastoma cells reveals cellular evasion mechanism counteracting dasatinib blockade of ERK activation during invasion
Marc Thomas Schönholzer, Jessica Migliavacca, Elena Álvarez, et al.
Neoplasia (2020) Vol. 22, Iss. 10, pp. 470-483
Open Access | Times Cited: 24
The Golgi Apparatus May Be a Potential Therapeutic Target for Apoptosis-Related Neurological Diseases
Qiang He, Hui Liu, Shuwen Deng, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 24
DNA or Protein Methylation-Dependent Regulation of Activator Protein-1 Function
Eunji Kim, Akash Ahuja, Mi‐Yeon Kim, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 461-461
Open Access | Times Cited: 22
CircRNA and lncRNA-associated competing endogenous RNA networks in medulloblastoma: a scoping review
Fatemeh Nejadi Orang, Mahdi Abdoli Shadbad
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
Sumana Shrestha, Alaide Morcavallo, Chiara Gorrini, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 18
EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors
Bárbara Kunzler Souza, Natália Hogetop Freire, Mariane da Cunha Jaeger, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11292-11292
Open Access | Times Cited: 15
Inhibition of Bone Morphogenetic Protein 2 Suppresses the Stemness Maintenance of Cancer Stem Cells in Hepatocellular Carcinoma via the MAPK/ERK Pathway
Juncheng Guo, Min Guo, Jinfang Zheng
Cancer Management and Research (2021) Vol. Volume 13, pp. 773-785
Open Access | Times Cited: 11
Overcoming Treatment Resistance in Medulloblastoma: Underlying Mechanisms and Potential Strategies
Hasan Slika, Aanya Shahani, Riddhpreet Kaur Wahi, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2249-2249
Open Access | Times Cited: 1
Epigenetic modulators for brain cancer stem cells: Implications for anticancer treatment
Luana Abballe, Evelina Miele
World Journal of Stem Cells (2021) Vol. 13, Iss. 7, pp. 670-684
Open Access | Times Cited: 9
Overview and recent advances in the targeting of medulloblastoma cancer stem cells
Megan Rose Paul, Peter E. Zage
Expert Review of Anticancer Therapy (2021) Vol. 21, Iss. 9, pp. 957-974
Open Access | Times Cited: 8
Epigenetic-Based Therapy—A Prospective Chance for Medulloblastoma Patients’ Recovery
Agata Strejczek, Dawid Woszczyk, Helena Urbaniak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4925-4925
Open Access | Times Cited: 7
Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR
Alice Laschuk Herlinger, Gustavo Lovatto Michaelsen, Marialva Sinigaglia, et al.
NeuroMolecular Medicine (2023) Vol. 25, Iss. 4, pp. 573-585
Open Access | Times Cited: 2
HDACs and MYC in medulloblastoma: how do HDAC inhibitors control MYC-amplified tumors?
Tomoko Shofuda, Yonehiro Kanemura
Neuro-Oncology (2020) Vol. 23, Iss. 2, pp. 173-174
Open Access | Times Cited: 4
EHMT2/G9a as an Epigenetic Target in Pediatric and Adult Brain Tumors
Bárbara Kunzler Souza, Natália Hogetop Freire, Mariane da Cunha Jaeger, et al.
(2021)
Open Access | Times Cited: 4
Enhancing targeted therapy by combining PI3K and AKT inhibitors with or without cisplatin or vincristine in medulloblastoma cell lines in vitro
Monika Lukoseviciute, E. Need, Madeleine Birgersson, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117500-117500
Open Access
Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition
Tingting Du, Xiaowen Hu, Zhenyan Hou, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access
Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma
Natália Hogetop Freire, Alice Laschuk Herlinger, Júlia Vanini, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top